Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Apogee Therapeutics (APGE) Tax Provisions (2024 - 2026)

Apogee Therapeutics (APGE) reported Tax Provisions of $79000.0 for Q1 2026, down 4.82% year-over-year from $83000.0 in Q1 2025, and up 27.42% on a QoQ basis from $62000.0 in Q4 2025.

Apogee Therapeutics (APGE) has 3 years of Tax Provisions data on file, last reported at $79000.0 in Q1 2026.

  • Quarterly Tax Provisions fell 4.82% year-over-year to $79000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $274000.0 (up 171.29% YoY) and the FY2025 annual result came in at $278000.0, up 1444.44% from the prior year.
  • Tax Provisions climbed to $79000.0 in Q1 2026 per APGE's latest filing, from $62000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $83000.0 in Q1 2025 and bottomed at $18000.0 in Q4 2024.
  • The 3-year median for Tax Provisions is $67000.0 (2025), against an average of $62500.0.
  • The widest annual swing landed in 2025, when Tax Provisions soared 244.44%; it then decreased 4.82% in 2026.
  • Tracing APGE's Tax Provisions over 3 years: stood at $18000.0 in 2024, then soared by 244.44% to $62000.0 in 2025, then rose by 27.42% to $79000.0 in 2026.
  • Per Business Quant, the three latest APGE Tax Provisions figures stand at $79000.0 (Q1 2026), $62000.0 (Q4 2025), and $61000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -11.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -859,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 221.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 216,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.66 Mn
10 Apogee Therapeutics 5.53 Bn 4.47 Bn - 79,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 79,000.00
Dec 31, 2025 62,000.00
Sep 30, 2025 61,000.00
Jun 30, 2025 72,000.00
Mar 31, 2025 83,000.00
Dec 31, 2024 18,000.00